North America Genotyping Market Forecast to 2031 – Regional Analysis – by Product Type (Instruments, Reagents and Kits, Bioinformatics, and Genotyping Services), Technology (Microarray, Capillary Electrophoresis, Sequencing, Polymerase Chain Reaction (PCR), Matrix-Assisted Laser Desorption / MALDI-TOF, and Other Technologies), Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Animal Genetics, Agricultural Biotechnology, and Other Applications), and End user (Pharmaceutical and Biopharmaceutical Companies, Diagnostic and Research Laboratories, Academic Institutes, and Other End Users)
The North America genotyping market was valued at US$ 12,044.57 million in 2023 and is expected to reach US$ 62,900.63 million by 2031; it is estimated to record a CAGR of 23.0% from 2023 to 2031.
Use in Diagnosis of Genetic and Rare Diseases Fuels North America Genotyping Market
According to the World Health Organization (WHO), ~35 million new cancer cases are likely to occur in 2050, a 77% increase from the corresponding 20 million cases in 2022. In 2022, the Alzheimer’s Association stated that the number of people living with Alzheimer’s in the US is rapidly increasing. The disease affects more than 6 million Americans from all age groups. As per the association’s estimates, 6.5 million Americans aged more than 65 suffered from Alzheimer's as of 2022, and 73% of this population was aged 75 or older. As per a study published in the Journal of Health Monitoring, up to 300 million people worldwide suffer from rare diseases. Although individual diseases are rare, they collectively pose significant challenges to the global healthcare system.
Since cancer, Alzheimer’s disease, and rare diseases are difficult to identify clinically, genotyping stands as the backbone of diagnostic testing in the population. DNA sequences obtained from genotyping can be compared to sample or reference sequences to determine variations. Genotyping is also employed to detect single-nucleotide polymorphisms (SNPs), which are minor variations in genetic complement within the population. The human genome has nearly 660 million SNPs, which makes them the most widespread genetic variation. Moreover, by comparing polymorphisms in healthy and diseased populations, genome-wide association studies (GWAS) can uncover links between common illnesses and SNPs. GWAS can untangle the molecular mechanisms in underlying disease states by finding probable causes. SNPs are even present in single-celled organisms, such as bacteria. SNP genotyping can discriminate between microorganism isolates and could even be accustomed to identifying antibiotic-resistant strains. SNP-based strain detection has a significant impact on each pharmaceutical and clinical analysis, and it has also been used in infectious disease epidemiology.
North America Genotyping Market Overview
The North America genotyping market is segmented into the US, Canada, and Mexico. Increasing adoption of technologically advanced products and solutions, and surging research and development activities are the factors benefiting the genotyping market in this region. Moreover, government-led programs such as the “All of Us Research Program,” initiatives by various genomic communities, and the increasing awareness of genotyping services are the key drivers of the market expansion across North America.
North America Genotyping Market Revenue and Forecast to 2031 (US$ Million)
North America Genotyping Market Segmentation
The North America genotyping market is categorized into product type, technology, application, end user, and country.
Based on product type, the North America genotyping market is segmented into instruments, reagents and kits, bioinformatics, and genotyping services. The reagents and kits segment held the largest market share in 2023.
By technology, the North America genotyping market is categorized into microarrays, capillary electrophoresis, sequencing, polymerase chain reaction (PCR), matrix-assisted laser desorption / MALDI-TOF, and other technologies. The polymerase chain reaction (PCR) segment held the largest market share in 2023.
Based on application, the North America genotyping market is segmented into pharmacogenomics, diagnostics and personalized medicine, animal genetics, agricultural biotechnology, and other applications. The diagnostics and personalized medicine segment held the largest market share in 2023.
In terms of end user, the North America genotyping market is bifurcated into pharmaceutical and biopharmaceutical companies, diagnostic and research laboratories, academic institutes, and other end users. The pharmaceutical and biopharmaceutical companies segment held the largest market share in 2023.
By country, the North America genotyping market is segmented into the US, Canada, and Mexico. The US dominated the North America genotyping market share in 2023.
Hoffmann-La Roche Ltd, QIAGEN NV, Merck KGaA, Thermo Fisher Scientific Inc, BioTek Instruments, Inc, TRIMGEN CORPORATION, Illumina Inc, Danaher Corp, Bio-Rad Laboratories Inc, GE HealthCare Technologies Inc, Standard BioTools Inc, Laboratory Corp of America Holdings, Beckman Coulter Inc, BGI, Takara Bio Inc, and DiaSorin SpA. are some of the leading companies operating in the North America genotyping market.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. North America Genotyping Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Global Market Share Analysis
4.3.1 Global Market Share (%) of Leading Players for NGS Library Preparation
4.3.2 Global Market Share (%) of Leading Player for Genotyping
4.3.3 Global Market Share (%) of Leading Player for Gene Expression
5. North America Genotyping Market – Key Market Dynamics
5.1 Market Drivers:
5.1.1 Use in Diagnosis of Genetic and Rare Diseases
5.1.2 Technological Advancements and Rising R&D Investments in Biotechnology and Pharmaceutical Industry
5.2 Market Restraints
5.2.1 High Cost of Equipment and Shortage of Skilled Professionals
5.3 Market Opportunities
5.3.1 Expanding Range of Applications
5.4 Future Trends
5.4.1 Increasing Popularity of Personalized Medicine
5.5 Impact of Drivers and Restraints:
6. Genotyping Market – North America Analysis
6.1 Genotyping Market Revenue (US$ Million), 2021–2031
7. North America Genotyping Market Analysis – by Product Type
7.1 Instruments
7.1.1 Overview
7.1.2 Instruments: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Reagents and Kits
7.2.1 Overview
7.2.2 Reagents and Kits: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Bioinformatics
7.3.1 Overview
7.3.2 Bioinformatics: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Genotyping Services
7.4.1 Overview
7.4.2 Genotyping Services: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Genotyping Market Analysis – by Technology
8.1 Microarray
8.1.1 Overview
8.1.2 Microarray: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Capillary Electrophoresis
8.2.1 Overview
8.2.2 Capillary Electrophoresis: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Sequencing
8.3.1 Overview
8.3.2 Sequencing: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Polymerase Chain Reaction (PCR)
8.4.1 Overview
8.4.2 Polymerase Chain Reaction (PCR): Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
8.5 Matrix-Assisted Laser Desorption / MALDI-TOF
8.5.1 Overview
8.5.2 Matrix-Assisted Laser Desorption / MALDI-TOF: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
8.6 Other Technologies
8.6.1 Overview
8.6.2 Other Technologies: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
9. North America Genotyping Market Analysis – by Application
9.1 Pharmacogenomics
9.1.1 Overview
9.1.2 Pharmacogenomics: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Diagnostics and Personalized Medicine
9.2.1 Overview
9.2.2 Diagnostics and Personalized Medicine: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Animal Genetics
9.3.1 Overview
9.3.2 Animal Genetics: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
9.4 Agricultural Biotechnology
9.4.1 Overview
9.4.2 Agricultural Biotechnology: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
9.5 Other Applications
9.5.1 Overview
9.5.2 Other Applications: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
10. North America Genotyping Market Analysis – by End-user
10.1 Pharmaceutical and Biopharmaceutical Companies
10.1.1 Overview
10.1.2 Pharmaceutical and Biopharmaceutical Companies: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
10.2 Diagnostic and Research Laboratories
10.2.1 Overview
10.2.2 Diagnostic and Research Laboratories: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
10.3 Academic Institutes
10.3.1 Overview
10.3.2 Academic Institutes: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
10.4 Other End Users
10.4.1 Overview
10.4.2 Other End Users: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11. North America Genotyping Market – Country Analysis
11.1 North America
11.1.1 North America: Genotyping Market – Revenue and Forecast Analysis – by Country
11.1.1.1 United States: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.1.1.1.1 United States: Genotyping Market Breakdown, by Product Type
11.1.1.1.2 United States: Genotyping Market Breakdown, by Technology
11.1.1.1.3 United States: Genotyping Market Breakdown, by Application
11.1.1.1.4 United States: Genotyping Market Breakdown, by End-user
11.1.1.2 Canada: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.1.1.2.1 Canada: Genotyping Market Breakdown, by Product Type
11.1.1.2.2 Canada: Genotyping Market Breakdown, by Technology
11.1.1.2.3 Canada: Genotyping Market Breakdown, by Application
11.1.1.2.4 Canada: Genotyping Market Breakdown, by End-user
11.1.1.3 Mexico: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
11.1.1.3.1 Mexico: Genotyping Market Breakdown, by Product Type
11.1.1.3.2 Mexico: Genotyping Market Breakdown, by Technology
11.1.1.3.3 Mexico: Genotyping Market Breakdown, by Application
11.1.1.3.4 Mexico: Genotyping Market Breakdown, by End-user
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in Genotyping Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Hoffmann-La Roche Ltd
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 QIAGEN NV
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Merck KGaA
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Thermo Fisher Scientific Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 BioTek Instruments, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 TRIMGEN CORPORATION
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Illumina Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Danaher Corp
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Bio-Rad Laboratories Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 GE HealthCare Technologies Inc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Standard BioTools Inc
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 Laboratory Corp of America Holdings
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
13.13 Beckman Coulter Inc
13.13.1 Key Facts
13.13.2 Business Description
13.13.3 Products and Services
13.13.4 Financial Overview
13.13.5 SWOT Analysis
13.13.6 Key Developments
13.14 BGI
13.14.1 Key Facts
13.14.2 Business Description
13.14.3 Products and Services
13.14.4 Financial Overview
13.14.5 SWOT Analysis
13.14.6 Key Developments
13.15 Takara Bio Inc
13.15.1 Key Facts
13.15.2 Business Description
13.15.3 Products and Services
13.15.4 Financial Overview
13.15.5 SWOT Analysis
13.15.6 Key Developments
13.16 DiaSorin SpA
13.16.1 Key Facts
13.16.2 Business Description
13.16.3 Products and Services
13.16.4 Financial Overview
13.16.5 SWOT Analysis
13.16.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms
List of Tables
Table 1. North America Genotyping Market Segmentation
Table 2. Genotyping Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 3. Genotyping Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 4. Genotyping Market – Revenue and Forecast to 2031 (US$ Million) – by Application
Table 5. Genotyping Market – Revenue and Forecast to 2031 (US$ Million) – by End-user
Table 6. United States: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 7. United States: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 8. United States: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 9. United States: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 10. Canada: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 11. Canada: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 12. Canada: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 13. Canada: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 14. Mexico: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type
Table 15. Mexico: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 16. Mexico: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 17. Mexico: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user
Table 18. Recent Organic Growth Strategies in Genotyping Market
Table 19. Recent Inorganic Growth Strategies in the Genotyping Market
Table 20. Glossary of Terms, Genotyping Market
List of Figures
Figure 1. North America Genotyping Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. Genotyping Market – Key Market Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Genotyping Market Revenue (US$ Million), 2021–2031
Figure 6. Genotyping Market Share (%) – by Product Type (2023 and 2031)
Figure 7. Instruments: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Reagents and Kits: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 9. Bioinformatics: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Genotyping Services: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Genotyping Market Share (%) – by Technology (2023 and 2031)
Figure 12. Microarray: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. Capillary Electrophoresis: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. Sequencing: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 15. Polymerase Chain Reaction (PCR): Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Matrix-Assisted Laser Desorption / MALDI-TOF: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 17. Other Technologies: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 18. Genotyping Market Share (%) – by Application (2023 and 2031)
Figure 19. Pharmacogenomics: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 20. Diagnostics and Personalized Medicine: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 21. Animal Genetics: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 22. Agricultural Biotechnology: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 23. Other Applications: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 24. Genotyping Market Share (%) – by End-user (2023 and 2031)
Figure 25. Pharmaceutical and Biopharmaceutical Companies: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 26. Diagnostic and Research Laboratories: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 27. Academic Institutes: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 28. Other End Users: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)
Figure 29. North America Genotyping Market, by Key Countries - Revenue (2023) (US$ Million)
Figure 30. North America: Genotyping Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 31. United States: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 32. Canada: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 33. Mexico: Genotyping Market – Revenue and Forecast to 2031(US$ Million)
Figure 34. Growth Strategies in Genotyping Market
- Hoffmann-La Roche Ltd.
- QIAGEN NV.
- Merck KGaA.
- Thermo Fisher Scientific Inc.
- BioTek Instruments, Inc.
- TRIMGEN CORPORATION.
- Illumina Inc.
- Danaher Corp.
- Bio-Rad Laboratories Inc.
- GE HealthCare Technologies Inc.
- Standard BioTools Inc.
- Laboratory Corp of America Holdings.
- Beckman Coulter Inc.
- BGI.
- Takara Bio Inc.
- DiaSorin SpA.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America genotyping market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America genotyping market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America genotyping market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.